HUM Humana Inc. Common Stock
关于 Humana Inc. Common Stock 公司概况(来自维基百科)
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
阅读更多
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
HUM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
HUM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年6月26日 | $0.8850 |
| 2026年3月27日 | $0.8850 |
| 2025年12月26日 | $0.8850 |
| 2025年9月26日 | $0.8850 |
| 2025年6月27日 | $0.8850 |
| 2025年3月28日 | $0.8850 |
| 2024年12月31日 | $0.8850 |
| 2024年9月30日 | $0.8850 |
| 2024年6月28日 | $0.8850 |
| 2024年3月27日 | $0.8850 |
| 2023年12月28日 | $0.8850 |
| 2023年9月28日 | $0.8850 |
| 2023年6月29日 | $0.8850 |
| 2023年3月30日 | $0.8850 |
| 2022年12月29日 | $0.7880 |
| 2022年9月29日 | $0.7880 |
| 2022年6月29日 | $0.7880 |
| 2022年3月30日 | $0.7880 |
| 2021年12月30日 | $0.7000 |
| 2021年9月29日 | $0.7000 |
HUM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 8 24.2%
- 买入 8 24.2%
- 持有 15 45.5%
- 卖出 2 6.1%
- 强烈卖出 0 0.0%
12个月价格目标
23 位分析师 · 2026-08-19收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $7.61 | $7.29 | 0.32% |
| 2026年3月31日 | $10.31 | $10.29 | 0.02% |
| 2025年12月31日 | $-3.96 | $-4.05 | 0.09% |
| 2025年9月30日 | $3.24 | $2.85 | 0.39% |
| 2025年6月30日 | $6.27 | $5.98 | 0.29% |
| 2025年3月31日 | $11.58 | $10.17 | 1.4% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
现金流 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
增长率 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
现金流 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
估值 (TTM) 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| 营业利润率 % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| 净收入 | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| 稀释后每股收益 (EPS) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| 流动比率 | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| 速动比率 | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $375M | $2.39B | $2.98B | $3.47B | $946M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 1050 家申报者 · $33.7B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 255 (+136 与上一季度对比) | 83 (-77 与上一季度对比) | 316 (+44 与上一季度对比) | 274 (-45 与上一季度对比) | +8.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Dodge & Cox | $4345737744 | 10940380 | 12.89% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3115642737 | 7843620 | 9.24% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2311405702 | 5818956 | 6.86% | 股份 |
| STATE STREET CORP | $2172441313 | 5457072 | 6.45% | 股份 |
| EAGLE CAPITAL MANAGEMENT LLC | $1528010749 | 3846762 | 4.53% | 股份 |
| Sessa Capital IM, L.P. | $1480732883 | 3727740 | 4.39% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1181074714 | 2976242 | 3.50% | 股份 |
| Capital International Investors | $950462637 | 2392826 | 2.82% | 股份 |
| NAYA CAPITAL MANAGEMENT UK LTD | $728407339 | 1833763 | 2.16% | 股份 |
| NORGES BANK | $694505009 | 1748414 | 2.06% | 股份 |
| GOLDMAN SACHS GROUP INC | $659096868 | 1659274 | 1.96% | 股份 |
| FMR LLC | $615633048 | 1549854 | 1.83% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544502820 | 1370784 | 1.62% | 股份 |
| Capital Research Global Investors | $443462035 | 1116990 | 1.32% | 股份 |
| Slate Path Capital LP | $428969795 | 1079930 | 1.27% | 股份 |
| Capital World Investors | $406119738 | 1022425 | 1.21% | 股份 |
| Newport Trust Company, LLC | $384768345 | 968653 | 1.14% | 股份 |
| CITADEL ADVISORS LLC | $363376856 | 914800 | 1.08% | 买入期权 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348908912 | 878377 | 1.04% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $331490508 | 834526 | 0.98% | 股份 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314921577 | 792814 | 0.93% | 股份 |
| CITADEL ADVISORS LLC | $310904094 | 782700 | 0.92% | 卖出期权 |
| WELLINGTON MANAGEMENT GROUP LLP | $282117958 | 710231 | 0.84% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $267791027 | 674163 | 0.79% | 股份 |
| Maple Rock Capital Partners Inc. | $249553862 | 628251 | 0.74% | 股份 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245555446 | 618185 | 0.73% | 股份 |
| GOLDMAN SACHS GROUP INC | $232333978 | 584900 | 0.69% | 买入期权 |
| MARSHALL WACE, LLP | $216873381 | 545978 | 0.64% | 股份 |
| CITADEL ADVISORS LLC | $178080082 | 448316 | 0.53% | 股份 |
| High Ground Investment Management LLP | $177941848 | 447968 | 0.53% | 股份 |
| 1832 Asset Management L.P. | $176401430 | 444090 | 0.52% | 股份 |
| BCV Asset Management Inc. | $173695656 | 445719 | 0.52% | 股份 |
| BANK OF AMERICA CORP /DE/ | $172703708 | 434781 | 0.51% | 股份 |
| Holocene Advisors, LP | $165040541 | 415489 | 0.49% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $147490964 | 371308 | 0.44% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $140098700 | 352698 | 0.42% | 股份 |
| JANE STREET GROUP, LLC | $137080622 | 345100 | 0.41% | 买入期权 |
| Swiss National Bank | $134522525 | 338660 | 0.40% | 股份 |
| JANE STREET GROUP, LLC | $122542370 | 308500 | 0.36% | 卖出期权 |
| STEADFAST CAPITAL MANAGEMENT LP | $122423204 | 308200 | 0.36% | 股份 |
| BlackRock, Inc. | $120890332 | 304341 | 0.36% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115565201 | 290935 | 0.34% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $109135401 | 274748 | 0.32% | 股份 |
| AMERIPRISE FINANCIAL INC | $108302217 | 272614 | 0.32% | 股份 |
| Legal & General Group Plc | $103424967 | 260372 | 0.31% | 股份 |
| Vanguard Global Advisers, LLC | $103330825 | 260135 | 0.31% | 股份 |
| GOLDMAN SACHS GROUP INC | $103078590 | 259500 | 0.31% | 卖出期权 |
| NEUBERGER BERMAN GROUP LLC | $102585352 | 258258 | 0.30% | 股份 |
| BANK OF NOVA SCOTIA | $102313941 | 257575 | 0.30% | 股份 |
| RHUMBLINE ADVISERS | $102294748 | 257527 | 0.30% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $101464685 | 255437 | 0.30% | 股份 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100979680 | 254216 | 0.30% | 股份 |
| Gotham Asset Management, LLC | $89318889 | 224860 | 0.27% | 股份 |
| Balyasny Asset Management L.P. | $87965958 | 221454 | 0.26% | 股份 |
| FIRST TRUST ADVISORS LP | $85094587 | 214226 | 0.25% | 股份 |
| Ensign Peak Advisors, Inc | $83532585 | 210293 | 0.25% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83463866 | 210120 | 0.25% | 股份 |
| Brandywine Global Investment Management, LLC | $80388706 | 313859 | 0.24% | 股份 |
| California Public Employees Retirement System | $80274587 | 202091 | 0.24% | 股份 |
| WOLVERINE TRADING, LLC | $76135109 | 298300 | 0.23% | 买入期权 |
| Camber Capital Management LP | $73344000 | 300000 | 0.22% | 股份 |
| National Pension Service | $70860473 | 178391 | 0.21% | 股份 |
| BARCLAYS PLC | $70472788 | 177415 | 0.21% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $69949250 | 176097 | 0.21% | 股份 |
| Walleye Trading LLC | $69473778 | 174900 | 0.21% | 买入期权 |
| CANADA PENSION PLAN INVESTMENT BOARD | $68018761 | 171237 | 0.20% | 股份 |
| ARGA Investment Management, LP | $66165730 | 166572 | 0.20% | 股份 |
| ORBIMED ADVISORS LLC | $65183802 | 164100 | 0.19% | 股份 |
| Solel Partners LP | $64742888 | 162990 | 0.19% | 股份 |
| AMF Tjanstepension AB | $61961951 | 155989 | 0.18% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60794124 | 153049 | 0.18% | 股份 |
| Perpetual Ltd | $57945659 | 145878 | 0.17% | 股份 |
| CI INVESTMENTS INC. | $57302560 | 144259 | 0.17% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $56575256 | 142426 | 0.17% | 股份 |
| Squarepoint Ops LLC | $56047742 | 141100 | 0.17% | 卖出期权 |
| Aberdeen Group plc | $53345852 | 134298 | 0.16% | 股份 |
| WOLVERINE TRADING, LLC | $52653949 | 206300 | 0.16% | 卖出期权 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52178000 | 131358 | 0.15% | 股份 |
| ING GROEP NV | $51583784 | 129862 | 0.15% | 股份 |
| Squarepoint Ops LLC | $50685272 | 127600 | 0.15% | 买入期权 |
| Walleye Trading LLC | $49573056 | 124800 | 0.15% | 卖出期权 |
| D. E. Shaw & Co., Inc. | $46514462 | 117100 | 0.14% | 买入期权 |
| BRAIDWELL LP | $45481690 | 114500 | 0.13% | 股份 |
| Jain Global LLC | $43694200 | 110000 | 0.13% | 卖出期权 |
| BANK OF MONTREAL /CAN/ | $43207208 | 108774 | 0.13% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42190325 | 106214 | 0.13% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42127167 | 106055 | 0.12% | 股份 |
| AVIVA PLC | $41509093 | 104499 | 0.12% | 股份 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41468472 | 161904 | 0.12% | 股份 |
| ROYAL BANK OF CANADA | $41033000 | 103301 | 0.12% | 股份 |
| Pentwater Capital Management LP | $39722000 | 100000 | 0.12% | 买入期权 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39284661 | 98899 | 0.12% | 股份 |
| Point72 Asset Management, L.P. | $39122595 | 98491 | 0.12% | 股份 |
| PFM Health Sciences, LP | $37487638 | 94375 | 0.11% | 股份 |
| Summit Street Capital Management, LLC | $36325372 | 91449 | 0.11% | 股份 |
| Columbus Hill Capital Management, L.P. | $35501935 | 89376 | 0.11% | 股份 |
| Korea Investment CORP | $34579193 | 87053 | 0.10% | 股份 |
| Quantinno Capital Management LP | $32817091 | 82616 | 0.10% | 股份 |
| Fisher Funds Management LTD | $32811563 | 82603 | 0.10% | 股份 |
| Swedbank AB | $32034603 | 80647 | 0.10% | 股份 |
公司内部人士 76 位内幕人士 · 46 位高管 · 27 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 2025年5月14日 P | 30474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 2024年2月21日 A | 110130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 2025年2月24日 A | 29676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 2024年12月31日 J | 20165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 2021年2月22日 A | 24342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 2014年5月9日 G | 14916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 2025年3月27日 J | 15702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 2025年2月24日 A | 16234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 2025年2月24日 A | 11566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 2023年2月24日 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 2022年12月15日 M | 3983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 2017年12月15日 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 2014年2月18日 A | 105443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 2017年3月31日 J | 34668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 2025年2月24日 A | 8628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 2025年2月24日 A | 1767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 2025年2月24日 A | 11266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 2025年2月24日 A | 17267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 2025年2月24日 A | 16717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 2024年12月31日 G | 7111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 2024年12月15日 M | 14015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 2024年2月21日 A | 11723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 2023年2月24日 F | 3687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 2022年5月1日 M | 4294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 2022年3月22日 J | 5723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 2022年2月25日 F | 6014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 2021年3月16日 G | 8168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 2019年12月18日 M | 18092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 2019年12月15日 M | 6339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 2019年2月25日 A | 9774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 2019年2月19日 M | 10791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 2018年12月15日 M | 11136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 2018年12月15日 M | 6476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 2017年3月17日 M | 4361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 2014年2月18日 A | 1101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 2014年2月18日 A | 15946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 2013年6月24日 M | 19347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 2012年12月24日 G | 2287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 2012年4月28日 F | 11946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 2012年2月23日 A | 23280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 2009年2月4日 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 2008年3月27日 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 2008年2月25日 F | 13836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 2007年12月31日 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 2007年2月23日 M | 57548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 2005年1月6日 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | 董事 | 2026年6月30日 A | 19448 | 0 | 0 | $0 |
| Frank A Damelio | 董事 | 2026年1月2日 A | 20634 | 0 | 0 | $0 |
| Karen Katz | 董事 | 2025年12月31日 A | 590 | 0 | 0 | $0 |
| David T Feinberg | 董事 | 2025年6月30日 A | 441 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| David A. Jones ×2 申报 | 2003年11月12日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 199 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded Alpha... | 2.95% | 109132 NS | 2026年4月30日 | N-PORT |
| SMRI · EA Series Trust | 2.54% | 58016 NS | 2026年4月30日 | N-PORT |
| TGLB · T. Rowe Price Exchange-Traded Fun... | 2.26% | 2111 NS | 2026年4月30日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.63% | 13322 NS | 2026年4月30日 | N-PORT |
| CVAR · ETF Opportunities Trust | 1.51% | 2473 NS | 2026年4月30日 | N-PORT |
| HWSM · HOTCHKIS & WILEY FUNDS /DE/ | 1.23% | 85 NS | 2026年6月30日 | N-PORT |
| EPMV · Harbor ETF Trust | 1.20% | 225 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 1.19% | 441 NS | 2026年5月29日 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds ... | 1.14% | 17702 NS | 2026年5月31日 | N-PORT |
| NUMV · Nushares ETF Trust | 0.96% | 17434 NS | 2026年4月30日 | N-PORT |
| FTA · First Trust Exchange-Traded Alpha... | 0.95% | 52223 NS | 2026年4月30日 | N-PORT |
| ITAN · EA Series Trust | 0.77% | 2259 NS | 2026年5月29日 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0.72% | 65925 NS | 2026年5月31日 | N-PORT |
| AUSF · Global X Funds | 0.70% | 19401 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.63% | 211 NS | 2026年5月31日 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.59% | 30459 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 0.53% | 1258 NS | 2026年5月31日 | N-PORT |
| FAB · First Trust Exchange-Traded Alpha... | 0.47% | 2755 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.46% | 55439 NS | 2026年4月30日 | N-PORT |
| FEX · First Trust Exchange-Traded Alpha... | 0.45% | 28340 NS | 2026年4月30日 | N-PORT |
| DEUS · DBX ETF Trust | 0.43% | 3849 NS | 2026年5月29日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.41% | 2404 NS | 2026年4月30日 | N-PORT |
| SPXD · DBX ETF Trust | 0.37% | 81 NS | 2026年5月31日 | N-PORT |
| QARP · DBX ETF Trust | 0.36% | 887 NS | 2026年5月29日 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.34% | 4484 NS | 2026年5月31日 | N-PORT |
| GMOV · GMO ETF Trust | 0.34% | 1004 NS | 2026年5月31日 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.32% | 265500 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.29% | 12439 NS | 2026年5月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.29% | 2779 NS | 2026年4月30日 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trus... | 0.28% | 1250 NS | 2026年5月31日 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds ... | 0.27% | 299 NS | 2026年5月31日 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0.26% | 12272 NS | 2026年4月30日 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.24% | 14039 NS | 2026年5月31日 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund ... | 0.21% | 4491 NS | 2026年5月31日 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.20% | 634 NS | 2026年5月31日 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0.18% | 708 NS | 2026年5月31日 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.16% | 3879 NS | 2026年4月30日 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund ... | 0.15% | 4555 NS | 2026年4月30日 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund ... | 0.15% | 24794 NS | 2026年4月30日 | N-PORT |
| CATH · Global X Funds | 0.13% | 6791 NS | 2026年4月30日 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.13% | 32836 NS | 2026年4月30日 | N-PORT |
| SCHG · SCHWAB STRATEGIC TRUST | 0.13% | 256808 NS | 2026年5月31日 | N-PORT |
| ACVF · ETF Opportunities Trust | 0.13% | 790 NS | 2026年4月30日 | N-PORT |
| OALC · Unified Series Trust | 0.12% | 945 NS | 2026年5月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.12% | 10240 NS | 2026年4月30日 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0.11% | 55850 NS | 2026年5月31日 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0.11% | 1461 NS | 2026年5月31日 | N-PORT |
| USSG · DBX ETF Trust | 0.11% | 2008 NS | 2026年5月29日 | N-PORT |
| VEGN · ETF Series Solutions | 0.10% | 675 NS | 2026年4月30日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.09% | 57804 NS | 2026年4月30日 | N-PORT |